Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has ...
The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--December 18, 2025-- Cartography Biosciences, Inc., a biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback